Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

By R. D’Agostino, S. Grundy, Lisa Sullivan, Peter W. F. Wilson, P. Wilson. Journal of the American Medical Association (JAMA), 2001

2,279 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/d3f979ca6d597799e7dbc141440eb43d5d380ca1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Endocrinology, Diabetes and Metabolism

In Radiology, Nuclear Medicine and Imaging

Ralph B. D’Agostino

Citations in the corpus

Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. (2004, methodology): “Similarly, although population characteristics changed in the Framingham cohort,(34) the present functions are still valid within US cohorts with more recent profiles of risk factors.(7) The success of the recalibrated Framingham functions in this Chinese cohort suggests that recalibration could be ”
Predictors of new-onset kidney disease in a community-based population. (2004, background): “However, the relationships of risk factors to coronary heart disease outcomes observed in Framingham Offspring Study have recently been validated in 6 ethnically and geographically diverse cohorts, and they were found to be applicable in other populations.(45) Although our use of long-term, averaged”
Comparing Ethnicity-Specific Reference Intervals for Clinical Laboratory Tests from EHR Data (2018, background): “However, this does not necessarilymean that the risk of a cardiovascular event at a given level of cholesterol differs between SIREs (37, 38).”
Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force (2002, positive): “Framingham data have recently been shown to generalize adequately to other populations (31).”
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010, neutral): “ome include diabetes as a risk factor (25).”
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. (2003, result): “In evaluating the internal validity of the risk score, we found that actual event rates were closely correlated with predicted event rates for participants at different levels of risk.(30) A formal test of this observation, the Hosmer-Lemeshow statistic, indicated good calibration, both for the over”
Presentation of multivariate data for clinical use: The Framingham Study risk score functions (2004, methodology): “Cox proportional hazards regression coe cients and means of the risk factors [12]: Example 5.”